MedPath

湖南德康制药股份有限公司

Ownership
-
Established
1993-07-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

50

NMPA:50

Drug Approvals

咳特灵胶囊

Approval Number
国药准字Z43020012
Approval Date
Aug 16, 2024
NMPA

回春如意胶囊

Approval Number
国药准字Z43020010
Approval Date
Aug 16, 2024
NMPA

Compound Bendazol and Hydrochlorothiazide Capsules

Product Name
复方地巴唑氢氯噻嗪胶囊
Approval Number
国药准字H43021786
Approval Date
Aug 16, 2024
NMPA

天麻首乌胶囊

Approval Number
国药准字Z20050023
Approval Date
Aug 16, 2024
NMPA

益脑胶囊

Approval Number
国药准字Z43020078
Approval Date
Aug 16, 2024
NMPA

银黄胶囊

Approval Number
国药准字Z20043968
Approval Date
Aug 14, 2024
NMPA

健脾益肾颗粒

Approval Number
国药准字Z43020047
Approval Date
May 10, 2024
NMPA

化瘀镇痛胶囊

Approval Number
国药准字B20020009
Approval Date
May 10, 2024
NMPA

伤科跌打片

Approval Number
国药准字Z43020015
Approval Date
May 10, 2024
NMPA

痔速宁片

Approval Number
国药准字Z43020009
Approval Date
Apr 29, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy